Speaker

Shawn Wang

Director, Head of Material Development, Kite Pharma

Shawn Wang, Director, Head of Material Development at Kite Pharma, spoke at 3rd Raw Materials for Cell & Gene Therapy Summit (San Diego, United States of America, 26–28 Oct 2026) in the session “Planning Material Grade Transitions Early to Avoid Late-Stage Requalification & Delayed Timelines”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

3rd Raw Materials for Cell & Gene Therapy Summit
26–28 Oct 2026San Diego, United States of America
- WorkshopPlanning Material Grade Transitions Early to Avoid Late-Stage Requalification & Delayed TimelinesWith Alison Burkart, Mayo Pujols
- PanelPanel Session: Navigating Supplier Diversification to Reduce Risk & Maintain Product ContinuityWith Lili Belcastro

More speakers at 3rd Raw Materials for Cell & Gene Therapy Summit

James Adams
Chief Technical Officer, Tr1x therapeutics
Daniel Anaya
Associate Director, MS&T, Ray Therapeutics
Benjamin Cho
Technical Development Scientist II, Genentech
Ben Clarke
Senior Scientist, Global Biologics, U.S. Pharmacopeia
Basak Clements
Independent Raw Materials Expert & USP CGT Expert Committee Member, Independent Expert
Aditya Dandekar
Associate Director, Cabaletta Bio

See all 15 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Shawn Wang, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].